stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Gross margin
QIAGEN N.V.'s gross margin over the twelve months to 30 June 2026 was 62.2%, up 0.0 percentage points from fiscal 2025 (62.2%). Over the past ten years it has ranged from 48.9% (fiscal 2024) to 66.7% (fiscal 2018); the current reading is higher than 18% of that period. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 62.2% | 13.28 |
| FY2024 | 48.9% | (13.87) |
| FY2023 | 62.8% | (1.88) |
| FY2022 | 64.7% | 0.22 |
| FY2021 | 64.4% | (1.48) |
| FY2020 | 65.9% | 0.05 |
| FY2019 | 65.9% | (0.79) |
| FY2018 | 66.7% | 1.57 |
| FY2017 | 65.1% | 1.95 |
| FY2016 | 63.1% | (1.40) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 63.6% | 0.73 |
| Mar 2026 | 62.9% | 2.70 |
| Dec 2025 | 60.2% | (2.01) |
| Sep 2025 | 62.2% | (0.45) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.2% |
| BLLN BillionToOne, Inc. compare | 71.4% |
| GH Guardant Health, Inc. compare | 65.2% |
| QGEN QIAGEN N.V. | 62.2% |
| RVTY Revvity Inc. compare | 55.9% |
| CRL Charles River Laboratories International, Inc. compare | 33.3% |
| ICLR ICON PLC compare | 23.4% |
| RDNT RadNet, Inc. compare | 11.5% |
| GRAL GRAIL, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement